166 related articles for article (PubMed ID: 34598035)
21. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
[TBL] [Abstract][Full Text] [Related]
22. Interaction analysis between germline genetic variants and somatic mutations in head and neck cancer.
Feng G; Feng H; Qi Y; Wang T; Ni N; Wu J; Yuan H
Oral Oncol; 2022 May; 128():105859. PubMed ID: 35428027
[TBL] [Abstract][Full Text] [Related]
23. Combined effect of tobacco and DNA repair genes polymorphisms of XRCC1 and XRCC2 influence high risk of head and neck squamous cell carcinoma in northeast Indian population.
Choudhury JH; Choudhury B; Kundu S; Ghosh SK
Med Oncol; 2014 Aug; 31(8):67. PubMed ID: 24958516
[TBL] [Abstract][Full Text] [Related]
24. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
Rasnic R; Brandes N; Zuk O; Linial M
BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
[TBL] [Abstract][Full Text] [Related]
25. Novel germline CDKN2A mutation associated with head and neck squamous cell carcinomas and melanomas.
Cabanillas R; Astudillo A; Valle M; de la Rosa J; Álvarez R; Durán NS; Cadiñanos J
Head Neck; 2013 Mar; 35(3):E80-4. PubMed ID: 22083977
[TBL] [Abstract][Full Text] [Related]
26. Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.
Van Allen EM; Lui VW; Egloff AM; Goetz EM; Li H; Johnson JT; Duvvuri U; Bauman JE; Stransky N; Zeng Y; Gilbert BR; Pendleton KP; Wang L; Chiosea S; Sougnez C; Wagle N; Zhang F; Du Y; Close D; Johnston PA; McKenna A; Carter SL; Golub TR; Getz G; Mills GB; Garraway LA; Grandis JR
JAMA Oncol; 2015 May; 1(2):238-44. PubMed ID: 26181029
[TBL] [Abstract][Full Text] [Related]
27. RAD51C--a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC).
Scheckenbach K; Baldus SE; Balz V; Freund M; Pakropa P; Sproll C; Schäfer KL; Wagenmann M; Schipper J; Hanenberg H
Oral Oncol; 2014 Mar; 50(3):196-9. PubMed ID: 24315737
[TBL] [Abstract][Full Text] [Related]
28. Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
Buckley AR; Ideker T; Carter H; Harismendy O; Schork NJ
Genome Med; 2018 Sep; 10(1):69. PubMed ID: 30217226
[TBL] [Abstract][Full Text] [Related]
29. Mutational and Functional Analysis of
Glaas MF; Wiek C; Wolter LM; Roellecke K; Balz V; Okpanyi V; Wagenmann M; Hoffmann TK; Grässlin R; Plettenberg C; Schipper J; Hanenberg H; Scheckenbach K
Anticancer Res; 2018 Mar; 38(3):1317-1325. PubMed ID: 29491055
[TBL] [Abstract][Full Text] [Related]
30. Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy.
Veeramachaneni R; Walker T; Revil T; Weck A; Badescu D; O'Sullivan J; Higgins C; Elliott L; Liloglou T; Risk JM; Shaw R; Hampson L; Hampson I; Dearden S; Woodwards R; Prime S; Hunter K; Parkinson EK; Ragoussis J; Thakker N
Sci Rep; 2019 Aug; 9(1):11992. PubMed ID: 31427592
[TBL] [Abstract][Full Text] [Related]
31. Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma.
Al-Amri AM; Vatte C; Cyrus C; Chathoth S; Hashim TM; Mohamed YS; Al Ali R; Alsaid A; Al Ali A
Cancer Biomark; 2016; 16(3):377-83. PubMed ID: 26889984
[TBL] [Abstract][Full Text] [Related]
32. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
33. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway.
García-Escudero R; Segrelles C; Dueñas M; Pombo M; Ballestín C; Alonso-Riaño M; Nenclares P; Álvarez-Rodríguez R; Sánchez-Aniceto G; Ruíz-Alonso A; López-Cedrún JL; Paramio JM; Lorz C
Oral Oncol; 2018 Apr; 79():55-63. PubMed ID: 29598951
[TBL] [Abstract][Full Text] [Related]
35. Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer.
Webster ALH; Sanders MA; Patel K; Dietrich R; Noonan RJ; Lach FP; White RR; Goldfarb A; Hadi K; Edwards MM; Donovan FX; Hoogenboezem RM; Jung M; Sridhar S; Wiley TF; Fedrigo O; Tian H; Rosiene J; Heineman T; Kennedy JA; Bean L; Rosti RO; Tryon R; Gonzalez AM; Rosenberg A; Luo JD; Carroll TS; Shroff S; Beaumont M; Velleuer E; Rastatter JC; Wells SI; Surrallés J; Bagby G; MacMillan ML; Wagner JE; Cancio M; Boulad F; Scognamiglio T; Vaughan R; Beaumont KG; Koren A; Imielinski M; Chandrasekharappa SC; Auerbach AD; Singh B; Kutler DI; Campbell PJ; Smogorzewska A
Nature; 2022 Dec; 612(7940):495-502. PubMed ID: 36450981
[TBL] [Abstract][Full Text] [Related]
36. The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer.
Esteban-Jurado C; Franch-Expósito S; Muñoz J; Ocaña T; Carballal S; López-Cerón M; Cuatrecasas M; Vila-Casadesús M; Lozano JJ; Serra E; Beltran S; Brea-Fernández A; Ruiz-Ponte C; Castells A; Bujanda L; Garre P; Caldés T; Cubiella J; Balaguer F; Castellví-Bel S
Eur J Hum Genet; 2016 Oct; 24(10):1501-5. PubMed ID: 27165003
[TBL] [Abstract][Full Text] [Related]
37. Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.
Schmitt K; Molfenter B; Laureano NK; Tawk B; Bieg M; Hostench XP; Weichenhan D; Ullrich ND; Shang V; Richter D; Stögbauer F; Schroeder L; de Bem Prunes B; Visioli F; Rados PV; Jou A; Plath M; Federspil PA; Thierauf J; Döscher J; Weissinger SE; Hoffmann TK; Wagner S; Wittekindt C; Ishaque N; Eils R; Klussmann JP; Holzinger D; Plass C; Abdollahi A; Freier K; Weichert W; Zaoui K; Hess J
Int J Cancer; 2019 Dec; 145(12):3299-3310. PubMed ID: 31135957
[TBL] [Abstract][Full Text] [Related]
38. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
[TBL] [Abstract][Full Text] [Related]
39. DNA repair genes XPC, XPD, XRCC1, and XRCC3 are associated with risk and survival of squamous cell carcinoma of the head and neck.
Farnebo L; Stjernström A; Fredrikson M; Ansell A; Garvin S; Thunell LK
DNA Repair (Amst); 2015 Jul; 31():64-72. PubMed ID: 26001739
[TBL] [Abstract][Full Text] [Related]
40. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
